About Us - Drug Development Technology

Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

APIs

Vaccine development: the need for speed

Lack of CMO availability threatens cell and gene therapy development

Novaliq’s NovaTears+Omega-3 represents the first-in-class omega-3-containing eye drop for evaporative dry eye

Approvals

DMAb trial for Zika prevention gets FDA approval

2018: The year’s biggest Drug Development Technology stories

FDA accelerated review denial is a blow to Spectrum’s poziotinib

Clinical Research

Women’s health pipeline: profiling the GCPR target class

FDA accelerated review denial is a blow to Spectrum’s poziotinib

Chinese biotech hits new heights with approval of first domestic checkpoint inhibitor

Clinical Trials

AbbVie’s imbruvica fails to meet pancreatic cancer trial objective

Lilly reports negative results from cancer drug trial

Xbrane receives approval to start trial of lucentis biosimilar

Diseases

Women’s health pipeline: profiling the GCPR target class

2018: The year’s biggest Drug Development Technology stories

FDA accelerated review denial is a blow to Spectrum’s poziotinib

Genomics & Proteomics

August’s top news stories

July’s top news stories

June’s top news stories

Market Data

Deals this week: Ferring Pharmaceuticals, Mirati, Juvenescence

M&As this week: Tabula Rasa, Generex, Flex Pharmaceuticals

Deals this week: Keros Therapeutics, Opollomics, CANbridge

Technology

September’s top news stories

August’s top news stories

July’s top news stories

Online

Read more

In Print

Read more